• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS25
Device Problems Material Too Rigid or Stiff (1544); Insufficient Information (3190)
Patient Problem Thrombocytopenia (4431)
Event Date 12/18/2023
Event Type  Injury  
Manufacturer Narrative
H3 other text : device remains implanted.
 
Event Description
On (b)(6)2023, a perceval valve pvs25 was implanted in a patient.Blood platelet has decreased right after the surgery and the patient required transfusion.However, the things did not go well.Reportedly, blood platelet was more than 100,000 /l before the surgery, which is under 10,000 /l now.No further information is available at this time.
 
Event Description
On (b)(6) 2023, a percival valve pvs25 was implanted in a patient.Blood platelet has decreased right after the surgery and the patient required all types of transfusion.However, the things did not go well.Reportedly, blood platelet was more than 100,000 /l before the surgery, which is under 10,000/l now.Based on the further information received, patient had no symptoms before hospitalization.During hospitalization, paigg antibodies were elevated, and patient was diagnosed with itp thrombocytopenia (which is complicated by myasthenia gravis).As such, treatment was started.Haptoglobin was measured for suspected hemolysis, and the value dropped, leading to suspicion of hemolysis due to artificial valve, but there were no problems with pvl or pressure gradient (no abnormalities in percival function).Cardiopulmonary bypass and cross-clamp time was reported as 111min and 83 min respectively.Reportedly, patient has a history of myasthenia gravis, copd asthma, diabetes, complete atrioventricular block which required ddd pacemaker implanted prior to percival operation.Patient's medications have been reported as: myasthenia gravis medicine, antihypertensive medicine, copd antiphlogistic medicine, diabetes medicine, laxatives.
 
Manufacturer Narrative
Manufacturer is retrieving and reviewing the products manufacturing records.A follow up report will be provided upon completion of this review or/and receipt of any additional information.
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model # icv1210, s/n # (b)(6) as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve has been manufactured and controlled in accordance with the specifications for a (model # icv1210) perceval heart valve at the time of manufacture and release.Based on the information available, it is not possible to draw a definitive root cause for the reported event.However, per the document review performed, no manufacturing deficiencies were identified with the perceval valve involved in the event.Thrombocytopenia (tcp) in cardiac surgery is a very well-known phenomenon.The etiology is multi-factorial due to multiple factors including hemodilution, blood loss with volume repletion with platelet-poor fluids, platelet activation, consumption and destruction due to contact with foreign surfaces.Tcp following aortic valve replacement (avr) is also a common phenomenon.Patient factors and prolonged extracorporeal circulation all being recognized predictors of tcp following cardiac surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc 
MDR Report Key18514982
MDR Text Key332898752
Report Number3004478276-2024-00111
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000436
UDI-Public(01)00896208000436(240)ICV1210(17)250302
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/26/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/02/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age81 YR
Patient SexMale
Patient Weight61 KG
-
-